• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溃疡性结肠炎。

Ulcerative colitis.

机构信息

University of Tennessee College of Medicine, Chattanooga, TN 37403, USA.

出版信息

Am Fam Physician. 2013 May 15;87(10):699-705.

PMID:23939448
Abstract

Ulcerative colitis is a chronic inflammatory disease of the colon. The etiology is unknown. Risk factors include a history of recent infection with Salmonella or Campylobacter, living in Western industrialized nations and at higher latitudes, and a family history of the disease. The incidence peaks in early adulthood, but patients can develop the disorder from early childhood through adulthood. Ulcerative colitis often presents with abdominal pain, diarrhea, and hematochezia. It is important to exclude infectious etiologies. Anemia and an elevated erythrocyte sedimentation rate or C-reactive protein level may suggest inflammatory bowel disease, but the absence of laboratory abnormalities does not rule out ulcerative colitis. The diagnosis is suspected clinically and confirmed through endoscopic biopsy. First-line treatment is therapy with 5-aminosalicylic acid. Corticosteroids may be added if 5-aminosalicylic acid therapy is ineffective. Infliximab can be added to induce and sustain remission. Patients with severe or nonresponsive ulcerative colitis should be hospitalized, and intravenous corticosteroids should be given. If medical management has been ineffective, surgical intervention is indicated for severe disease. Patients with ulcerative colitis have an increased risk of colon cancer and should have periodic colonoscopy beginning eight to 10 years after diagnosis.

摘要

溃疡性结肠炎是一种结肠的慢性炎症性疾病。病因不明。危险因素包括近期感染沙门氏菌或弯曲杆菌、居住在西方国家和高纬度地区、以及家族病史。发病高峰在成年早期,但患者可从儿童期到成年期发病。溃疡性结肠炎常表现为腹痛、腹泻和血便。重要的是要排除感染性病因。贫血和红细胞沉降率或 C 反应蛋白水平升高可能提示炎症性肠病,但实验室异常的缺乏并不排除溃疡性结肠炎。诊断是基于临床怀疑并通过内镜活检来确认。一线治疗是使用 5-氨基水杨酸治疗。如果 5-氨基水杨酸治疗无效,可以添加皮质类固醇。英夫利昔单抗可用于诱导和维持缓解。患有严重或无反应性溃疡性结肠炎的患者应住院,并给予静脉皮质类固醇。如果药物治疗无效,则应进行手术干预严重疾病。溃疡性结肠炎患者患结肠癌的风险增加,应在诊断后 8 至 10 年内定期进行结肠镜检查。

相似文献

1
Ulcerative colitis.溃疡性结肠炎。
Am Fam Physician. 2013 May 15;87(10):699-705.
2
Ulcerative colitis: diagnosis and treatment.溃疡性结肠炎:诊断与治疗
Am Fam Physician. 2007 Nov 1;76(9):1323-30.
3
Ulcerative colitis: pathogenesis, diagnosis, and current treatment.溃疡性结肠炎:发病机制、诊断及当前治疗方法
J Assoc Acad Minor Phys. 1996;7(3):63-9.
4
Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.溃疡性结肠炎和克罗恩病女性的分娩结局以及抗炎药物治疗的药物流行病学方面
Dan Med Bull. 2011 Dec;58(12):B4360.
5
[Management of diagnosis and treatment in ulcerative colitis].[溃疡性结肠炎的诊断与治疗管理]
Presse Med. 2015 Feb;44(2):144-9. doi: 10.1016/j.lpm.2014.06.025. Epub 2014 Dec 19.
6
Induction of remission by interferon-alpha in patients with chronic active ulcerative colitis.α-干扰素诱导慢性活动性溃疡性结肠炎患者缓解
Eur J Gastroenterol Hepatol. 1995 Jul;7(7):597-602.
7
[Differential diagnosis of ulcerative colitis].[溃疡性结肠炎的鉴别诊断]
Nihon Rinsho. 1999 Nov;57(11):2461-5.
8
Paediatric inflammatory bowel disease in New Zealand.新西兰的儿童炎症性肠病
N Z Med J. 2008 Oct 3;121(1283):19-34.
9
Ulcerative colitis in children and adolescents from the Western Region of Saudi Arabia.沙特阿拉伯西部地区儿童及青少年的溃疡性结肠炎
Saudi Med J. 2011 Sep;32(9):943-7.
10
[Diagnostic guideline of ulcerative colitis].[溃疡性结肠炎诊断指南]
Korean J Gastroenterol. 2009 Mar;53(3):145-60.

引用本文的文献

1
A new approach for microbe-disease association prediction: incorporating representation learning of latent relationships.一种微生物-疾病关联预测的新方法:纳入潜在关系的表征学习。
BMC Med Inform Decis Mak. 2025 Jul 18;25(1):270. doi: 10.1186/s12911-025-03093-6.
2
Ulcerative colitis after Salmonella infection.沙门氏菌感染后引发的溃疡性结肠炎
J Gen Fam Med. 2025 Feb 14;26(4):363-364. doi: 10.1002/jgf2.70001. eCollection 2025 Jul.
3
Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-analysis.
中重度活动性溃疡性结肠炎诱导和维持期先进疗法的疗效与安全性:系统文献综述和贝叶斯网络荟萃分析
J Comp Eff Res. 2025 May;14(5):e240225. doi: 10.57264/cer-2024-0225. Epub 2025 Mar 17.
4
Mechanism of Wuling powder modulating proBDNF/p75NTR/sortilin and BDNF/TrkB pathways in the treatment of ulcerative colitis complicated with depression.五苓散调控proBDNF/p75NTR/ sortilin和BDNF/TrkB通路治疗溃疡性结肠炎合并抑郁症的机制
World J Gastroenterol. 2025 Feb 28;31(8):100227. doi: 10.3748/wjg.v31.i8.100227.
5
Patchoulene epoxide mitigates colitis and hepatic damage induced by dextran sulfate sodium by regulating the colonic microbiota and purine metabolism.广藿香环氧物通过调节结肠微生物群和嘌呤代谢减轻葡聚糖硫酸钠诱导的结肠炎和肝损伤。
Front Immunol. 2025 Feb 14;16:1509114. doi: 10.3389/fimmu.2025.1509114. eCollection 2025.
6
Sinomenine hydrochloride improves DSS-induced colitis in mice through inhibition of the Notch signaling pathway.盐酸青藤碱通过抑制Notch信号通路改善右旋糖酐硫酸钠诱导的小鼠结肠炎。
BMC Gastroenterol. 2024 Dec 18;24(1):451. doi: 10.1186/s12876-024-03546-8.
7
Patient perception of bowel urgency and remission in moderately to severely active Crohn's disease or ulcerative colitis: a qualitative study.中重度活动期克罗恩病或溃疡性结肠炎患者对肠道急迫感和缓解的感知:一项定性研究。
J Patient Rep Outcomes. 2024 Nov 12;8(1):130. doi: 10.1186/s41687-024-00800-1.
8
Therapeutic and Immunologic Effects of Short-Chain Fatty Acids in Inflammatory Bowel Disease: A Systematic Review.短链脂肪酸在炎症性肠病中的治疗和免疫效应:系统评价。
Int J Mol Sci. 2024 Oct 10;25(20):10879. doi: 10.3390/ijms252010879.
9
Integrative biomarker discovery and immune profiling for ulcerative colitis: a multi-methodological approach.溃疡性结肠炎的综合生物标志物发现和免疫特征分析:一种多方法学研究。
Sci Rep. 2024 Oct 16;14(1):24290. doi: 10.1038/s41598-024-75797-0.
10
Mutational analysis differentiating sporadic carcinomas from colitis-associated colorectal carcinomas.突变分析将散发性癌与结肠炎相关的结直肠癌区分开来。
Cell Commun Signal. 2024 Oct 10;22(1):483. doi: 10.1186/s12964-024-01856-8.